Effects of a new antiestrogen, keoxifene (LY156758), on growth of carcinogen-induced mammary tumors and on LH and prolactin levels
- 31 May 1983
- journal article
- research article
- Published by Elsevier BV in Life Sciences
- Vol. 32 (25), 2869-2875
- https://doi.org/10.1016/0024-3205(83)90323-5
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- EVIDENCE FOR BIOLOGICAL ACTION OF THE ANTIESTROGENS LY117018 AND TAMOXIFEN BY DIFFERENT MECHANISMSEndocrinology, 1981
- High-affinity anti-oestrogen binding site distinct from the oestrogen receptorNature, 1980
- Uterine bioassay of tamoxifen, trioxifene and a new estrogen antagonist (LY117018) in rats and miceLife Sciences, 1980
- Clinical trial of 2-Br-α-ergocryptine (CB154) in advanced breast cancerEuropean Journal of Cancer (1965), 1972
- Anti-oestrogens and breast cancerEuropean Journal of Cancer (1965), 1971